Bone Proteome Study in Ovariectomised Rats Supplemented with Palm Vitamin E

Authors: Patrick Nwabueze Okechukwu, Ima Nirwana Soelaiman, Gabriele Anisah Ruth Froemming, Mohd Yusri Idorus, Norazlina Mohamed

Abstract:

Supplementation of palm vitamin E has been reported to prevent loss of bone density in ovariectomised female rats. The mechanism by which palm vitamin E exerts these effects is still unknown. We hypothesized that palm vitamin E may act by preventing the protein expression changes. Two dimensional poly acyrilamide gel electrophoresis (2-D PAGE) and PD Quest software genomic solutions Investigator (proteomics) was used to analyze the differential protein expression profile in femoral and humeri bones harvested from three groups of rats; sham-operated rats (SO), ovariectomised rats (Ovx) and ovariectomised rats supplemented for 2 months with palm vitamin E. The results showed that there were over 300 valued spot on each of the groups PVE and OVX as compared to about 200 in SO. Comparison between the differential protein expression between OVX and PVE groups showed that ten spots were down –regulated in OVX but up-regulated in PVE. The ten differential spots were separately named P1-P10. The identification and understanding of the pathway of the differential protein expression among the groups is ongoing and may account for the molecular mechanism through which palm vitamin E exert its anti-osteoporotic effect.

Keywords: Palm vitamin E, ovariectomised, osteoporosis protein expression, 2-d-page.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1075312

References:

[1] Michaëlsson,K., Melhus,H., Ferm,H., 2005. Genetic liability to fractures in the elderly Arch. Intern. Med. 165:1825-1830.
[2] Slemenda, C.W., Christian,J.C., Williams,C.J. et al., 1991. Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates" J. Bone Miner. Res. 6:561-567.
[3] Pooneh, S. and Mohammad, A. 2011. A comprehensive review of the shared roles of inflammatory cytokines in osteoporosis and cardiovascular disease as two common old people problem; actions towards development of new drugs" International Journal of Pharmacology 7(5): 552-567.
[4] Kong,Y.Y., Feige,U., Sarosi, Iet al., 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand" Nature 402:304-309.
[5] Manolagas, S.C., 2000. Birth and death of bone cells: Basic regulatory mechanism and implications for the pathogenesis and treatment of osteoporosis" Endocrinol.Rev., 21: 115-137.
[6] Goa,Y., Grassi, F, Robbie,M, Terauchi,M et al., 2007. IFN-╬│ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation" J.Clin Invest., 117:122-132.
[7] Miyaura,C., Kusano,K., Masuzawa,T., et al., 1995. Endogenous boneresorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6 J.Bone. Miner.Res., 10: 1365-1373.
[8] De Martins, M., Di Benedetto,M.C., Mengoli L.P., et al., 2006. Senile osteoporosis: Is it an immune-mediated disease" Inflamm. Res., 55: 399- 404.
[9] Lacativa,P.G. and Farias, M.L, 2010. Osteoporosis and inflammatory Arq. Bras. Endocrinol Metab., 54:123-132.
[10] Roggia,C. Gao,Y., Cenci, S., Weitzmann, M.N et al 2001. Upregulation of TNF producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl.Acad.Sci. USA, 98: 13960-13965.
[11] Cenci,S. Toraldo,G., Weitzmann,M.N., Roggia C. et al., 2003. Estrogen deficiency induces bone loss by increasing T cell proliferation and life span through IFN-gamma-induced class II transactivator" Proc.Natl.Acad. Sci USA., 100: 10405-10410.
[12] Serbinova,E.A. 1991. Alpha Tocotrienol Is A More Powerful membrane Antioxidant Than Alpha Tocopherol", Oxid Damage Repair;77-81.
[13] Norazlina,M., Ling,H.L.R., Ima-Nirwana , S. et al., 2002. The effect of vitamin E or calcium supplementation on bone mineral composition in vitamin E deficient rats" Malaysia J. Biochem. Biol., 7: 1-5.
[14] Norazlina, M., Ima-Nirwana, S., Abd Gapor, M.T et al., 2002. Tocotrienols are needed for normal bone calcification in growing female rats. Asia Pacific J. Clin. Nutr., 11: 194-199.
[15] Norazlina, M., Ima-Nirwana, S., Gapor ,M.T., et al. 2000. Palm vitamin E is comparable to alpha - tocopherol in maintaining bone mineral density in ovariectomised female rats, Exp. Clin. Endocrinol. Diab., 108: 305-310.
[16] Ima-Nirwana,S., Kiftiah, A., Sariza,T., Gapor,M.T., et al., 1999. Palm vitamin E improves bone metabolism and survival rate in thyrotoxic rats. Gen. Pharm., 32: 621-626.
[17] Nazrun, A.S., Norazlina,M., Norliza ,M., et al.2011. Tocotrienols as an Anti-Osteoporotic Agent: The Progress So Far." International Journal of Osteoporosis and Metabolic Disorders, 4: 1-14.
[18] Asmadi, A.Y.,Adam,A., Wan Ngah,W.Z., et al 2005. Tocotrienols and ╬▒- Tocopherol reduced acute and chronic lung lipid peroxidation induced by paraquat in rats. Pak. J. Nutr., 4: 97-100.
[19] Nur Azlina,M.F., Nafeeza,M.I., Khalid , B.A.K. et al 2005. Effect of tocotrienol on lipid peroxidation in experimental gastritis induced by restraint stress. Pak. J. Nutr 4: 69-72 .
[20] Fan, Y. Liu, J., Wang,S. et al 2005.Functional proteome of bones in rats with osteoporosis following ovariectomy. Life Sciences 76 :2893- 2901.
[21] Shen, S.H. Jing, Y.X. . Kuang , T.Y et al., 2003. Proteomics approach to identify wound-response related proteins from rice leaf sheath. Proteomics 3, 527-535.
[22] Mosekilde, L.and Mosekilde,L., et a 1990. Sex-difference in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone 11: 67-73.
[23] Kalu, D.N. 1991. The ovariectomised rat model of postmenopausal bone loss. Bone Miner., 15: 175-191.
[24] Ima-Nirwana S., Norazlina, M.. Khali B.A.K d, et al 1998. Pattern of bone mineral density in growing male and female rats gonadectomy. J. Asean. Fed. Endoc. Soc 16: 21-26.
[25] Sack, M.N. Rader , D.J. Cannon R.O, et al 1994. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women" Lancet 343:269-270.
[26] Basu, S., Michaelsson,K., Olofsson,H., et al 2001. Association between oxidative stress and bone mineral density" Biochem. Biophys. Res. Commun., 288: 275-279.
[27] Badeau,M. Adlercreutz,H., Kaihovara,P., et al 2005. Estrogen A-ring structure and antioxidant effect on lipoproteins. J. Steroid Biochem. Mol. Biol,. 96: 271-278.
[28] Maggio,D., Barabani,M., Pierandrei,M., Polidori, M.C., et al 2003. Marked decrease in plasma antioxidant in aged osteoporotic women: Results of a cross-sectional study. J. Clin Endo, Metab., 88: 1523-1527 2003.
[29] Lean, J.M., Jagger, C.J. Kirsten, B. Fuller K., et al 2005. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinol, 146: 728-735.
[30] Ahmad, N.S. Khalid, B.A.K., Luke, D.A. , et al. 2005. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone" Clin. Exp. Pharm. Physiol., 32: 761-770.
[31] Norazlina, M., Lukman, H.I, Nazrun A.S. , et al., 2007. Effects of vitamin E supplementation on bone metabolism in nicotine-treated rats Singapore Med. J. 48: 195-199.
[32] Hammer C.T and Wills E.D 1978. The role of lipid components of the diet in the regulation of the fatty acid composition of the rat liver endoplasmic reticulum and lipid peroxidation" Biochem. J., 174: 585- 595.
[33] Maniam, S. N. Mohamed,N. Shuid , A.N. et al., 2008. Palm tocotrienol exerted better antioxidant activities in bone than alpha-tocopherol. Basic Clin . Pharmacol.Toxicol., 103: 55-60.
[34] Wilkins, M. R., Pasquali, C., Appel, R. D., et al ".1996. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis." Biotechnology 14, 61-65.
[35] Kim, S. H. Jun, S. Hee-Sun, J. Sung-Kil, Let al 2005. Identification of parathyroid hormone-regulated proteins in mouse bone marrow cells by proteomics" Biochemical and Biophysical Research Communications 330 423-429.
[36] Chapam,C.M, Beilby, J.P., Humphries,S.E., et al 2003. Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian Community population" Eur. Heart. J., 24: 1494-1499, 2003.
[37] Manolagas S.G.and Jilka R.L. 1995. Mechanisms of disease: Bone marrow, cytokines and bone remodeling- emerging insights into the pathophysiology of osteoporosis" N. Engl. J. Med, 332:305-311.
[38] Scheidt-Nave,C. Bismar,H., Leidig-Bruckner,G. et al 2001. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J. Clin. Endocrinol Metab., 86: 2032-2042.
[39] Berton, B.E. 1996. The biological effects of interleukin 6" Med.Res. Rev., 1:87-109.
[40] Tabibzadeh,S.S. Santhanam,U., Sehgal,P.B. et al 1989. Cytokine induced production of IFN-β 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol 17β. J. Immunol., 142: 3134-3139.
[41] Wu, S.J., Liu, P.L,.Ng et al L.T., 2008. Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells" Mol. Nutr. Food Res 52: 921-929.
[42] B.C. Pearce, R.A. Parker, M.E. Deason, et al " Hypercholesterolaemic activity of synthetic and natural tocotrienol. J. Med Chem., 35: 3595- 3606, 1992.
[43] Salari,P., Larijiani,B. Abdollahi,M. et al 2008. Association of hyperhomocysteinemia with osteoporosis: A systematic review. Therapy, 5: 215-222.
[44] Sharif ,P.S., Asalforoush, M. Ameri, F.et al 2010. The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: A randomized clinical trial. Age, 32: 179-186.
[45] Sharif, P.S. Nikfar, S. Abdollahi, M.et al. 2011. Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: A meta- analysis. Volume 33, number 3, 421-431.
[46] Sun,D., Krishnan, A., Zaman,K., et al 2003. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J. Bone Miner. Res., 18: 1206-1216.